Nonprescription Magnesium Supplement Use and Risk of Heart Failure in Patients With Diabetes: A Target Trial Emulation
Long-term nonprescription magnesium supplement use was associated with a lower risk of incident HF and major adverse cardiac events in patients with diabetes. These findings should be replicated in randomized controlled trials.
Authors
- Wen‐Chih Wu (ORCID: https://orcid.org/0000-0002-2834-2024)
- Andrew R. Zullo (ORCID: https://orcid.org/0000-0003-1673-4570)
- Yan Cheng (ORCID: https://orcid.org/0000-0001-7189-3991)
- Qing Zeng‐Treitler (ORCID: https://orcid.org/0000-0002-8353-7473)
- Yijun Shao (ORCID: https://orcid.org/0000-0001-6419-7963)
- Ying Yin (ORCID: https://orcid.org/0000-0001-8581-9696)
- Simin Liu (ORCID: https://orcid.org/0000-0003-2098-3844)
Institutions
- John Brown University (US)
- George Washington University (US)
- University of California, Irvine (US)
- Brown University (US)
- Providence VA Medical Center (US)
- University of California System (US)
- Washington DC VA Medical Center (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1161/jaha.124.038870
- Citations
- 3
- Primary Topic
- Magnesium in Health and Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.36